Renal Clinics Will Pay $4M To Settle Investors' Fraud Claims

By Dunstan Prial ( January 31, 2018, 9:53 PM EST) -- Private equity-backed American Renal Associates Holdings Inc. on Wednesday agreed to pay $4 million to a class of shareholders who claimed in Massachusetts federal court that the dialysis clinic operator artificially inflated its stock price and misled investors by making false statements related to allegations of insurance fraud around the time of its 2016 initial public offering....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!